Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02747537
Title Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With Sorafenib in Combination With Irinotecan
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Washington University School of Medicine

Advanced Solid Tumor


Irinotecan + Sorafenib

Age Groups: child | adult
Covered Countries

Additional content available in CKB BOOST